Literature DB >> 6402856

Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor.

G Pastore, N Tannoia, G Angarano, L Monno, T Santantonio, A Pietrapertosa, G Malcangi, A Putignano, O Schiraldi.   

Abstract

To evaluate the effective role of hepatitis viruses in thalassemic (Th) liver disease, we carried out a long-term study in 42 subjects with nontransfusion-dependent Th minor hospitalized for an episode of acute viral hepatitis. 10 patients had serologic evidence of hepatitis A, 23 of hepatitis B and 9 of hepatitis non-A, non-B. In the follow-up chronic hepatitis was detected histologically in 5/23 patients with hepatitis B and 5/9 with hepatitis non-A, non-B. All hepatitis A patients recovered completely. The prevalence in 7 out of 10 patients with chronic hepatitis of piecemeal necrosis and of inflammatory changes over hepatic siderosis and fibrosis evidenced a determinant role of chronic viral infection in the development of liver damage in these patients. Thus, heterozygous nontransfusion-dependent Th patients seem to have a high risk of developing a chronic inflammatory liver disease especially after an episode of non-A, non-B hepatitis. Therefore, in our geographical area, chronic hepatitis of viral origin should be taken into account, among other pathogenetic factors, in many cases of cryptogenic thalassemic liver disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402856     DOI: 10.1111/j.1423-0410.1983.tb04098.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis.

Authors:  M Resti; C Azzari; M E Rossi; C Vullo; E Zammarchi; A Vierucci
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

2.  Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.

Authors:  G A Moroni; G Piacentini; S Terzoli; G Jean; G Masera
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.